Showing results (91-100 of 136) with videos related to
Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognitionTamson V Moore, Gretchen E Lyons, Natasha Brasic, et al.Papillomavirus Research (Amsterdam, Netherlands)|May 17, 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulationAndrew W Woodham, Lisa Yan, Joseph G Skeate, et al.Human Immunology|August 23, 2005
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitroDominic E Warrino, Walter C Olson, Meera I Scarrow, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapyMaurizio Chiriva-Internati, Leonardo Mirandola, Yuefei Yu, et al.The American Journal of Pathology|February 13, 2002
Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cellsI Caroline Le Poole, Adam I Riker, M Eugenia Quevedo, et al.Plos One|August 29, 2012
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionAndrew W Woodham, Diane M Da Silva, Joseph G Skeate, et al.Frontiers in Immunology|November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.International Reviews of Immunology|January 19, 2012
Perspective for prophylaxis and treatment of cervical cancer: an immunological approachMarjorie Jenkins, Maurizio Chiriva-Internati, Leonardo Mirandola, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2014
Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppressionAndrew W Woodham, Adam B Raff, Laura M Raff, et al.International Reviews of Immunology|January 19, 2012
Immunological treatment options for locoregionally advanced head and neck squamous cell carcinomaChristopher Schutt, Klaus Bumm, Leonardo Mirandola, et al.Pageof 14